Kolaja Carey OConnor
Director at Revance Therapeutics, Inc.
- Sold, on record
- $71k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Jun 15, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Revance Therapeutics, Inc.Director
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice Revance Therapeutics, Inc.NoticeJun 15, 2023 2023
Filed to sell 2,500 shares ($71k)
Kolaja Carey OConnor, Director
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale Revance Therapeutics, Inc.RoutineJun 15, 2023 same day
Sold 2,500 shares at $28.24 ($71k)
Kolaja Carey OConnor, Director
10b5-1 planSold 13.1% of holdings ($538k position)16,561 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 | Jun 20, 2023 | Revance Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $71k | 13.1% | Routine | SEC |
| Jun 15, 2023 | Jun 15, 2023 | Revance Therapeutics, Inc. | Director | Form 144 notice | 2,500 | $71k | Notice | SEC |